DOAJ Open Access 2025

Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)

Ashot A. Avagimyan Mohammad Sheibani Artem I. Trofimenko Evgenii E. Lysov Farida M. Khamidova +13 lainnya

Abstrak

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are now uncovering new possibilities in the field of internal medicine owing to their diverse protective effects. In the second part of the literature review, we explore potential applications of SGLT2i in hepatology, neurology, ophthalmology, and oncology, mechanisms of action of such drugs as dapagliflozin, empagliflozin, canagliflozin, etc, and their effect on different organs and systems.

Penulis (18)

A

Ashot A. Avagimyan

M

Mohammad Sheibani

A

Artem I. Trofimenko

E

Evgenii E. Lysov

F

Farida M. Khamidova

A

Anahit Z. Aznauryan

L

Lilit M. Sukiasyan

K

Karmen T. Sahakyan

T

Tamara R. Gevorgyan

M

Marina R. Tatoyan

G

Gayane L. Mkrtchyan

G

Goharik L. Meltonyan

A

Anna R. Petrosyan

L

Ludmila A. Martemyanova

R

Ruzanna R. Petrosyan

O

Olga I. Urazova

N

Nana V. Pogosova

N

Nizal Sarrafzadegan

Format Sitasi

Avagimyan, A.A., Sheibani, M., Trofimenko, A.I., Lysov, E.E., Khamidova, F.M., Aznauryan, A.Z. et al. (2025). Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2). https://doi.org/10.35401/2541-9897-2025-10-1-101-109

Akses Cepat

Informasi Jurnal
Tahun Terbit
2025
Sumber Database
DOAJ
DOI
10.35401/2541-9897-2025-10-1-101-109
Akses
Open Access ✓